MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-09-2026
Myomo Operating Income 2011-2026 | MYO
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Myomo
| 2025 | 2024 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -14.4 M | -6.21 M | -10.7 M | -10.3 M | -10.5 M | -10.8 M | -10.5 M | -6.55 M | -3.28 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -3.28 M | -14.4 M | -9.24 M |
Quarterly Operating Income Myomo
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.52 M | -4.59 M | -3.52 M | - | -958 K | -1.12 M | -3.89 M | - | -2.02 M | -1.1 M | -2.67 M | - | -2.82 M | -2.9 M | -2.74 M | - | -2.03 M | -2.6 M | -2.93 M | - | -2.55 M | -2.85 M | -3.42 M | - | -2.83 M | -2.71 M | -2.68 M | - | -2.71 M | -2.68 M | -2.4 M | - | -1.43 M | -1.93 M | -1.36 M | - | -934 K | -689 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -689 K | -4.59 M | -2.43 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Medtronic PLC
MDT
|
5.96 B | $ 87.12 | 0.62 % | $ 112 B |  USA |
 |
BioSig Technologies
BSGM
|
-12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Second Sight Medical Products
EYES
|
-24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 2.13 | 6.22 % | $ 1.29 M | USA |
 |
Orthofix Medical
OFIX
|
-81.4 M | $ 11.97 | 2.13 % | $ 474 M |  Curacao |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Inogen
INGN
|
-30.2 M | $ 6.3 | -0.4 % | $ 168 M | USA |
 |
IRadimed Corporation
IRMD
|
26.1 M | $ 102.82 | 1.83 % | $ 1.31 B | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
LENSAR
LNSR
|
-10.7 M | $ 5.66 | 1.8 % | $ 65.2 M | USA |
 |
Insulet Corporation
PODD
|
474 M | $ 225.87 | 0.16 % | $ 15.9 B | USA |
 |
AxoGen
AXGN
|
-7.85 M | $ 33.16 | 1.69 % | $ 1.53 B | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 36.85 | 0.72 % | $ 1.14 B | USA |
 |
AVITA Medical
RCEL
|
-42.5 M | $ 4.04 | 5.21 % | $ 113 M |  Australia |
 |
NanoVibronix
NAOV
|
-3.58 M | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
9.66 M | $ 24.7 | 0.2 % | $ 209 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
Cytosorbents Corporation
CTSO
|
-16.8 M | $ 0.65 | -7.27 % | $ 35.4 M | USA |
 |
Aethlon Medical
AEMD
|
-9.34 M | $ 2.25 | 3.94 % | $ 3.51 M | USA |
 |
InspireMD
NSPR
|
-49.6 M | $ 1.79 | 1.13 % | $ 115 M |  Israel |
 |
Profound Medical Corp.
PROF
|
-30.3 M | $ 5.23 | 1.55 % | $ 180 M | Canada |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Sintx Technologies
SINT
|
-10.7 M | $ 2.62 | 1.95 % | $ 7.27 M | USA |
 |
AdaptHealth Corp.
AHCO
|
90.9 M | $ 11.61 | 1.13 % | $ 1.57 B | USA |
 |
Smith & Nephew plc
SNN
|
593 M | $ 32.46 | 0.92 % | $ 23.8 B |  Britain |
 |
Penumbra
PEN
|
189 M | $ 335.79 | 0.46 % | $ 13.1 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-56.7 M | $ 2.4 | - | $ 141 M | Israel |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 3.69 | -5.63 % | $ 138 M |  France |
 |
Sensus Healthcare
SRTS
|
-10.3 M | $ 3.96 | - | $ 64.7 M | USA |
 |
Quanterix Corporation
QTRX
|
-126 M | $ 3.95 | 3.4 % | $ 168 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 16.04 | 0.82 % | $ 376 M | USA |
 |
Outset Medical
OM
|
-66.7 M | $ 3.56 | 0.85 % | $ 54.2 K | USA |